PDL BioPharma, Inc. Operating Cash Flow Margin

Operating Cash Flow Margin of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow Margin growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Cash Flow Margin for the quarter ending June 29, 2020 was -387.74% (a 52.38% increase compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow Margin increased by 403.95%
  • Annual Operating Cash Flow Margin for 2019 was -59.25% (a 773.89% increase from previous year)
  • Annual Operating Cash Flow Margin for 2018 was -6.78% (a -153.43% decrease from previous year)
  • Annual Operating Cash Flow Margin for 2017 was 12.69% (a -69.52% decrease from previous year)
  • Twelve month Operating Cash Flow Margin ending June 29, 2020 was -170.98% (a 103.6% increase compared to previous quarter)
  • Twelve month trailing Operating Cash Flow Margin increased by 1051.38% year-over-year
Trailing Operating Cash Flow Margin for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-170.98% -83.98% -59.25% -14.85%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow Margin of PDL BioPharma, Inc.

Most recent Operating Cash Flow Marginof PDLI including historical data for past 10 years.

Interactive Chart of Operating Cash Flow Margin of PDL BioPharma, Inc.

PDL BioPharma, Inc. Operating Cash Flow Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -387.74% -254.45%
2019 537.45% -76.94% 308.18% -34.39% -59.25%
2018 -4.58% 12.37% -13.39% -35.1% -6.78%
2017 -25.63% -5.66% 11.01% 100.75% 12.69%
2016 23.54% -16.2% 10.67% 89.7% 41.64%
2015 39.36% 60.57% 60.88% 47.99% 51.06%
2014 58.97% 46.83% 47.93% 49.81% 50.29%
2013 52.9% 45.74% 73.97% 57.55% 59.12%
2012 58.32% 42.04% 83.32% 23.14% 55.79%
2011 62.01% 43.83% 82.76% -15.78% 46.9%
2010 39.39% 35.5% 80.35% 53.42%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.